54 Scientists Call for Targeted Anti-Aging Research

Posted at CureAging.org

Scientists’ Open Letter on Aging Research

To whom it may concern,

Aging has been slowed and healthy lifespan prolonged in many disparate animal models (C. elegans, Drosophila, Ames dwarf mice, etc.). Thus, assuming there are common fundamental mechanisms, it should also be possible to slow aging in humans.

Greater knowledge about aging should bring better management of the debilitating pathologies associated with aging, such as cancer, cardiovascular disease, type II diabetes, and Alzheimer’s. Therapies targeted at the fundamental mechanisms of aging will be instrumental in counteracting these age-related pathologies.

Therefore, this letter is a call to action for greater funding and research into both the underlying mechanisms of aging and methods for its postponement. Such research may yield dividends far greater than equal efforts to combat the age-related diseases themselves. As the mechanisms of aging are increasingly understood, increasingly effective interventions can be developed that will help prolong the healthy and productive lifespans of a great many people.

Sincerely (54 Signatories)

Signatures From Leading Aging Researchers

•   Prof. Vladimir N. Anisimov Head of the Department of Carcinogenesis and Oncogerontology, N.N. Petrov Research Institute of Oncology, Russia; Author of Carcinogenesis and Aging and of Molecular and Physiological   Mechanisms of Aging. [04/18/2005]
• Bruce N. Ames, Ph.D. Professor University of California, Berkeley, Senior Scientist Children’s Hospital Oakland Research Institute; U.S. National Medal of Science; Research in delaying the mitochondrial decay of aging.
• Robert Arking, Ph.D. Professor, Dept. of Biological Sciences, Wayne State University; Research focused on understanding the mechanisms underlying the onset of senescence in Drosophila; Author of Biology of Aging: Observations and Principles.
• Steven N. Austad, Ph.D. Professor, Department of   Biological Sciences at the University of Idaho; Author of Why We Age: What Science Is Discovering about the Body’s Journey   Through Life and numerousother aging research publications.
• Nir Barzilai, M.D. Director of the Institute for   Aging Research at the Albert Einstein College of Medicine; Author of numerous       aging research publications; Founder of the Longevity Genes Project.
• Brian F.C. Clark, Ph.D., ScD. CoFounder of Senetek PLC, Professor of Biostructural Chemistry, Aarhus University, Denmark, Centre Leader of the Danish Centre of Molecular Gerontology.
• Antonei B. Csoka,    Ph.D.    Assistant Professor,  Department of Obstetrics, Gynecology and   Reproductive Sciences, Division of Developmental and Regenerative Medicine, University of Pittsburgh, Magee-Womens Research Institute; Research led to the   discovery of the gene that causes Hutchinson-Gilford   Progeria syndrome.
• Richard G. Cutler, Ph.D, Vice President of   Kronos Science Laboratories, Inc.,  Longevity Sciences Group; founder of Genox Corporation; Proposed and tested the Longevity Determinant Gene Hypothesis the Dysdifferentiation Hypothesis of Aging and the oxidative stress as a primary mechanism of aging model.
• Aubrey D.N.J. de   Grey, Ph.D. Department of Genetics, University of Cambridge,  United Kingdom; Founder of the Strategies for   Engineered Negligible Senescence (SENS) approach to anti-aging medicine; Editor-in-chief of Rejuvenation Research.
• João Pedro de Magalhães,  Ph.D. Ph.D. in Biological Sciences from the University of   Namur in Belgium; Postdoctoral fellow at Harvard Medical School; Author of a   number of publications on aging; Designed and implemented the Human Ageing Genomic   Resources. 
• Joseph M. Erwin, Ph.D. Independent Consultant and Executive Director, Foundation for Comparative & Conservation Biology; Adjunct Professor, Biomedical Sciences & Pathobiology and VA-MD Regional College of Veterinary Medicine at Virginia Tech; Senior Fellow, Center for Conservation and Behavior at Georgia Tech; Co-editor of Aging In Nonhuman Primates.
• Leonid A. Gavrilov,  Ph.D.    Center on Aging, NORC at the University of Chicago, Chicago; Author of The Biology   of Life Span; Founder of the Reliability Theory of Aging. 
• Natalia S. Gavrilova, Ph.D. Center on Aging, NORC at the University of Chicago, Chicago; Co-author   of The Biology of Life   Span;  Author of over a hundred scientific   publications on aging and   longevity studies.
• David Gems, Ph.D. UCL Centre for Research on Ageing,  Department of Biology,  University College London; Author of numerous aging research publications.
• David Gershon, Ph.D. Skillman Professor of Biomedical Sciences, Technion-Israel Institute of Technology;  Chief Science Officer, Redox Pharmaceutical Corp.
• Christopher B. Heward, Ph.D. Ph.D. in Biology   from the University of Arizona; Senior Research Fellow in the UCLA Program on   Medicine, Technology, and Society; President of Kronos Science Laboratories,  Inc. 
• Matt Kaeberlein, Ph.D. Ph.D. in Biology   from The Massachusetts Institute of Technology; Faculty member, The Basic Biology   of Aging at the University of Washington; Co-founder, Longenity Inc. 
• Alexander V. Khalyavkin, Ph.D. Academic Secretary, Gerontological Society of RAS, Moscow Branch; Academic Secretary, Problem Committee “Physiology & Biology of Aging”, Joint Scientific Council on Gerontology and Geriatrics, Russian Academy of Medical Sciences and Health Ministry; Author of the concept an organism’s non-senescence due to vital regimens, evoked by positive environmental influences or artificial cues.
• Marios Kyriazis, M.D. M.D. from the Univerisity of Rome; MSc in Gerontology from the University of London, King’s College; President of the British Longevity Society; Author of Carnosine: And Other Elixirs of Youth.
• Don A. Kleinsek,  Ph.D. Received a Ph.D. from the University of Wisconsin at Madison in Physiological Chemistry. President and founder of GeriGene Medical Corporation, in Madison, Wisc. GeriGene’s mission is to stop the aging process. 
• Peter M. Lansdorp M.D., Ph.D. Professor of Medicine, University of British Columbia; Senior ScientistTerry Fox Laboratory, B.C. Cancer Research Center; major focus of research on genetic instability in aging and cancer, publications. 
• Marc S. Lewis, Ph.D. Ph.D. from the University of Cincinnati in Clinical Psychology. Associate Professor at the University of Texas at Austin of Clinical Psychology. Research is focused on the interface of molecular biology and epidemiology with an emphasis on the molecular biology of aging.
• Valter Longo, Ph.D. Professor and researcher at the University of Southern California Leonard Davis School of Gerontology, Assistant Professor of Gerontology and Biological Science, Cell Biology and genetics, regulation of aging and multiple stress resistance systems in yeast and mammals, Alzheimer’s Disease.   
• Alvaro Macieira-Coelho, M.D. Director at the French National Institute of Health (INSERM) in France; Author of numerous books on aging such as Biology of Aging: Progress in Molecular and Subcellular Biology, Cell Immortalization and Cancer and Aging.
• George M.  Martin, M.D. Professor Emeritus of Pathology, University of   Washington.
• Brian J. Morris, Ph.D. Professor of Molecular Medical Sciences in the School of Medical Sciences of the Faculty of Medicine at The University of Sydney; has over 230 publications; research focusing on the alteration in genome-wide expression profiles during ageing of human cells. [10/116/05]
• S. Jay Olshansky, Ph.D. Professor of Epidemiology & Biostatistics at the School of Public Health at the University of Illinois; Co-author with Bruce Carnes of The Quest for Immortality: Science at the Frontiers of Aging.
• Suresh Rattan, Ph.D., D.Sc. Professor, Danish Centre for Molecular Gerontology, Department of Molecular Biology, University of Aarhus, Denmark; Editor-in-Chief Biogerontology; Editor of Aging Interventions and Therapies; Research areas and expertise: cellular aging, hormesis (mild stress-mediated aging interventions); gerontogenes.”   
• Robert J. Shmookler Reis, Ph.D. Professor, Depts. of Geriatrics, Medicine, Biochemistry & Molec.Biol., and Pharmacology; University of Arkansas for Medical Sciences and Career Health Scientist, Central Arkansas Veterans Healthcare Service. 
• Karl T. Riabowol, Ph.D. Professor of Biochemistry & Molecular Biology and Director of the Laboratory of Aging and Immortalization, University of Calgary; Member, Canadian Institutes of Health Research Institute of Aging Advisory Board; extensive publications on aging research.
• Arlan G.  Richardson, Ph.D. Director, Barshop   Institute for Longevity and Aging Studies, The University of Texas Health   Science Center at San Antonio.
• Michael R. Rose, Ph.D. Professor in the   Department of Ecology and Evolutionary Biology at the School of Biological   Sciences, University of California, Irvine; Author of Evolutionary Biology of Aging. 
• Stanley Shostak, Ph.D. Department Biological Sciences, University of Pittsburgh; Author Becoming Immortal: Combining Cloning and Stem-Cell Therapy and a number of other aging research publications.
• Rafal Smigrodzki, M.D., Ph.D. Chief Clinical Officer, Gencia Company; Charlottesville VA, publications on aging and genetics research
• Michael D.  West, Ph.D. Founder of Geron Corporation; Director of Biotime, Inc., BioMarker   Pharmaceuticals, Inc., and the Life Extension Foundation; President of Advanced Cell Technology,  Inc.; Author of The Immortal Cell: One Scientist’s Quest to Solve the Mystery of   Human Aging.
• Prof. Jan Vijg Principal investigator at the Functional Genomics of Aging research program which is located at the South Texas Center for Biology in Medicine at the Texas Research Park. It is part of the Sam and Ann Barshop Center for Longevity and Aging Studies.
• Prof. Thomas von Zglinicki Professor of Cellular Gerontology, University of Newcastle; Henry Wellcome Laboratory for Biogerontology, Newcastle General Hospital; extensive publications on aging and telomere research.

Signatures From Additional Leading Scientists  

• Nick Bostrom, Ph.D. Director, Oxford Future of Humanity Institute, Faculty of Philosophy, Oxford University.
• Daniel Crevier, Ph.D. Massachusetts Institute of Technology; Former professor, McGill University, Université du Québec.; Founder: Coreco Inc.; Author, AI: The Tumultuous History of the Search for Artificial Intelligence. Basic Books.
• Gregory Fahy, Ph.D. Chief Scientific Officer, Vice President; 21st Century Medicine, Inc.; Published a number of articles on organ perfusion, vitrification and cryopreservation.
• Robert A. Freitas Jr., J.D. Senior Research Fellow, Institute for Molecular Manufacturing; Author of Nanomedicine and Kinematic Self-Replicating Machines.
• Ben Goertzel, Ph.D. Ph.D. in Mathematics from Temple University; Chief Scientific Officer, Biomind LLC, creating AI-based software for the analysis of gene expression data.
• Amara Graps, Ph.D. Ph.D. in Astrophysics from the University of Heidelberg, Germany; Planetary scientist at the Institute of the Physics of Interplanetary Space in Rome, Italy; Published articles on astronomical dust physics and charging and scientific computing. 
• Robin Hanson, Ph.D. Associate Professor of Economics, George Mason University
• James J. Hughes, Ph.D. Executive Director, Institute for Ethics and Emerging Technologies; author Citizen Cyborg; Public Policy Studies, Trinity College, Hartford Connecticut.
• Subhash C. Kak, Ph.D. Department of Electrical & Computer Engineering, Louisiana State University, Baton Rouge, LA.
• James B. Lewis, Ph.D. (Chemistry, Harvard) Senior Research Investigator (retired); Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle, WA
• Max More, Ph.D. Founder, Extropy Institute; Author of the Proactionary Principle; Austin, TX
• Brad F. Mellon, STM, Ph.D. Chair of the Ethics Committee; Frederick Mennonite Community; Frederick, PA
• Steve Omohundro, Ph.D. (Physics, University of California at Berkeley) Past computer science professor at the University of Illinois at Champaign/Urbana; President, Self-Aware Systems
• Martine Rothblatt, Ph.D., J.D., M.B.A. Responsible for launching several satellite communications companies including Sirius and WorldSpace. Founder and CEO of United Therapeutics. Lead the International Bar Association’s project to develop a draft Human Genome Treaty for the United Nations.  Filed the first court motion on AI Legal Rights.
• Sergey V. Sheleg, M.D., Ph.D., Chief Research Scientist, Alcor Life Extension Foundation; M.D. from the Belarus State Medical University and Ph.D. in Oncology from N.N. Alexandrov Research Institute of Oncology and Medical Radiology (Lesnoy, Belarus). More than 20 published papers in the fields of neuro-oncology, neuro-infectious diseases, brain anoxia, and molecular cell biology
• Gregory Stock, Ph.D. Ph.D. in Biophysics from Johns Hopkins University; MBA from Harvard; Director of the Program on Medicine, Technology, and Society at UCLA’s School of Public Health; Author of Redesigning Humans: Our Inevitable Genetic Future.
• Brian Wowk, Ph.D. Ph.D. in Medical Physics from the University of Manitoba, Canada; Senior Scientist 21st Century Medicine, Inc.; Published a number of articles on medical physics, vitrification and cryopreservation.